These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 32156457

  • 1. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
    Modesto A, Dalmasso C, Lusque A, Vieillevigne L, Izar F, Moyal E, Carrère N, Guimbaud R, Rives M.
    Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
    [Abstract] [Full Text] [Related]

  • 2. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.
    Roeder F, Nicolay NH, Nguyen T, Saleh-Ebrahimi L, Askoxylakis V, Bostel T, Zwicker F, Debus J, Timke C, Huber PE.
    Radiat Oncol; 2014 Aug 29; 9():191. PubMed ID: 25175056
    [Abstract] [Full Text] [Related]

  • 3. Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.
    O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM.
    Cancer J; 2007 Aug 29; 13(2):119-24. PubMed ID: 17476140
    [Abstract] [Full Text] [Related]

  • 4. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
    Chen J, Su T, Lin Y, Wang B, Li J, Pan J, Chen C.
    Clin Transl Oncol; 2018 Mar 29; 20(3):411-419. PubMed ID: 28779422
    [Abstract] [Full Text] [Related]

  • 5. Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study.
    Yamashita M, Takenaka HY, Nakagawa K.
    Hepatogastroenterology; 2014 Oct 29; 61(135):1971-8. PubMed ID: 25713897
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.
    Zhu HT, Ai DS, Tang HR, Badakhshi H, Fan JH, Deng JY, Zhang JH, Chen Y, Zhang Z, Xia Y, Guo XM, Jiang GL, Zhao KL.
    World J Gastroenterol; 2017 Jan 21; 23(3):540-546. PubMed ID: 28210091
    [Abstract] [Full Text] [Related]

  • 7. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF, Lang K, Verma V, Koerber SA, Uhlmann L, Debus J, Sterzing F.
    Radiat Oncol; 2017 Aug 15; 12(1):131. PubMed ID: 28810885
    [Abstract] [Full Text] [Related]

  • 8. Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.
    McDowell LJ, Huang SH, Xu W, Che J, Wong RKS, Brierley J, Kim J, Cummings B, Waldron J, Bayley A, Hansen A, Witterick I, Ringash J.
    Int J Radiat Oncol Biol Phys; 2017 May 01; 98(1):186-195. PubMed ID: 28258892
    [Abstract] [Full Text] [Related]

  • 9. [Definitive or neo-adjuvant chemoradiation in esophageal carcinoma?].
    Modesto A, Carrère N, Guimbaud R, Rives M, Deutsch É, Quéro L, Créhange G.
    Cancer Radiother; 2019 Oct 01; 23(6-7):716-719. PubMed ID: 31421997
    [Abstract] [Full Text] [Related]

  • 10. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
    Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):581-6. PubMed ID: 22137021
    [Abstract] [Full Text] [Related]

  • 11. Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.
    Pöttgen C, Gkika E, Stahl M, Abu Jawad J, Gauler T, Kasper S, Trarbach T, Herrmann K, Lehmann N, Jöckel KH, Lax H, Stuschke M.
    Radiat Oncol; 2021 Mar 23; 16(1):59. PubMed ID: 33757534
    [Abstract] [Full Text] [Related]

  • 12. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
    Agarwal MS, Hitchcock KE, Morris CG, George TJ, Mendenhall WM, Zlotecki RA.
    Curr Oncol; 2019 Aug 23; 26(4):e515-e521. PubMed ID: 31548820
    [Abstract] [Full Text] [Related]

  • 13. Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.
    Bascoul-Mollevi C, Gourgou S, Galais MP, Raoul JL, Bouché O, Douillard JY, Adenis A, Etienne PL, Juzyna B, Bedenne L, Conroy T.
    Eur J Cancer; 2017 Oct 23; 84():239-249. PubMed ID: 28829992
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
    Gerber N, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA.
    Dis Esophagus; 2014 Apr 23; 27(3):235-41. PubMed ID: 23796070
    [Abstract] [Full Text] [Related]

  • 15. Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Ge X, Yang X, Lu X, Wen W, Zhen F, Ye H, Zhu H, Cao Y, Zhang S, Cheng H, Ma J, Yang B, Dai S, Guo Q, Cai J, Sun X.
    Tumori; 2015 Apr 23; 101(2):168-73. PubMed ID: 25791535
    [Abstract] [Full Text] [Related]

  • 16. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
    Cheng N, Liu Y, Zhao G, Xu Y, Zhang T, Chen Y, Yan G, Hu Y, Yao S, Wang Z, Wang C, Chen Z, Hu Z, Liu D, Chen T.
    Int J Radiat Oncol Biol Phys; 2020 Feb 01; 106(2):340-348. PubMed ID: 31655197
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Gkika E, Gauler T, Eberhardt W, Stahl M, Stuschke M, Pöttgen C.
    Dis Esophagus; 2014 Feb 01; 27(7):678-84. PubMed ID: 24147973
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR, Greco FA, Meluch AA, Lane CM, Farley C, Gray JR, Clark BL, Burris HA, Hainsworth JD.
    J Clin Oncol; 2010 May 01; 28(13):2213-9. PubMed ID: 20351330
    [Abstract] [Full Text] [Related]

  • 19. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
    Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, Brierley J, Wong R, Dinniwell R, Bayley AJ, Dawson LA, Ringash J, Krzyzanowska MK, Moore MJ, Chen EX, Easson AM, Kassam Z, Cho C, Kim J.
    Int J Radiat Oncol Biol Phys; 2014 Nov 01; 90(3):587-94. PubMed ID: 25194664
    [Abstract] [Full Text] [Related]

  • 20. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J, Rivin Del Campo E, Blanc J, Peiffert D, Benezery K, Pereira R, Rio E, Le Prisé E, Créhange G, Huguet F.
    Int J Radiat Oncol Biol Phys; 2019 Oct 01; 105(2):329-337. PubMed ID: 31299242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.